Narcolepsy With Cataplexy

15 clinical trials · Condition

Record	Firm	Date
An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy (NCT05055024)	NLS Pharmaceutics	2021-10-26
Awareness and Self-Compassion Enhancing Narcolepsy Treatment (NCT04306952)	Northwestern University	2020-06-15
'A Profile of Physical Performance Variables in an Out-patient Adult Population With Narcolepsy' (NCT04419792)	University of Dublin, Trinity College	2019-10-15
Clarithromycin Mechanisms in Hypersomnia Syndromes (NCT04026958)	Emory University	2019-09-04
A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy (NCT03030599)	Jazz Pharmaceuticals	2017-03-14
Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period (NCT02611687)	Bioprojet	2016-06-06
Xyrem and Brain Dopamine in Narcolepsy (NCT02637076)	Centre for Addiction and Mental Health	2016-01-01
A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy (NCT02221869)	Jazz Pharmaceuticals	2014-10-01
Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP) (NCT01800045)	Bioprojet	2013-04-01
Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes (NCT00345800)	UCB Pharma SA	2006-04-10
Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy (NCT03433131)	Harmony Biosciences Management, Inc.

Track Narcolepsy With Cataplexy automatically

Every clearance here is in the API, with alerts when new ones post.